regulatori
cell
treg
subset
cell
maintain
immun
homeostasi
prevent
autoimmun
suppress
autoreact
regul
immun
respons
foreign
selfantigen
hallmark
treg
express
transcript
factor
high
level
receptor
alpha
chain
due
role
maintain
immun
homeostasi
toler
treg
consid
potenti
immunotherapi
prevent
varieti
immunolog
diseas
human
among
potenti
diseas
may
tackl
immunemodul
graft
versu
host
diseas
gvhd
frequent
often
sever
complic
follow
allogen
hematopoiet
cell
transplant
murin
studi
demonstr
convinc
evid
power
treg
cell
therapi
prevent
treat
variou
immunolog
condit
multipl
sclerosi
gvhd
inflammatori
bowel
diseas
lupu
translat
studi
human
therapeut
applic
one
major
limit
expans
treg
ex
vivo
achiev
consist
suffici
number
puriti
bona
fide
treg
peripher
blood
healthi
adult
treg
within
total
cell
sinc
intracellular
transcript
factor
cell
low
high
express
ie
sort
function
isol
puriti
howev
popul
homogen
treg
particularli
diseas
marker
less
correl
due
activ
cell
establish
two
subset
treg
develop
thymu
ttreg
gener
peripheri
ptreg
moreov
cell
induc
vitro
tcr
stimul
presenc
express
itreg
function
pattern
differ
subgroup
treg
wide
vari
expans
treg
week
period
addit
puriti
composit
treg
frequenc
respect
ttreg
itreg
ptreg
nontreg
also
vari
result
impur
treg
product
demonstr
previous
itreg
lack
cardin
featur
ttreg
base
anergi
suppress
function
cell
isol
facssort
frequent
percentag
cell
decreas
two
week
three
week
expans
due
limit
hinder
advanc
treg
analysi
therapi
develop
innov
techniqu
repurifi
treg
expand
cultur
contamin
activ
nontreg
target
select
express
latencyassoci
peptid
lap
novel
method
allow
expans
consist
repurif
suffici
quantiti
highli
purifi
bona
fide
treg
even
initi
limit
blood
volum
ml
without
techniqu
difficult
analyz
assess
definit
function
treg
due
variabl
contamin
nontreg
moreov
method
potenti
optim
treg
therapi
permit
manufactur
treg
product
consist
bona
fide
treg
regardless
method
expans
donor
variabl
use
lap
marker
select
isol
lap
treg
time
point
expans
typic
contamin
nontreg
puriti
select
allow
separ
differ
subset
definit
determin
treg
function
gvhd
anoth
import
factor
cost
effect
product
treg
product
studi
use
cell
isol
buffi
coat
microbead
cell
expand
artifici
apc
aapc
express
repurifi
base
lap
express
perform
analysi
tcr
repertoir
function
phenotyp
within
cell
subset
lap
treg
lap
nontreg
isol
expans
cultur
demonstr
lap
treg
ex
vivo
expans
still
maintain
divers
tcr
repertoir
highli
demethyl
tsdr
region
possess
suppress
function
contrast
lap
nontreg
possess
suppress
function
parent
popul
variabl
function
depend
level
expand
contamin
nontreg
studi
demonstr
simpl
singlestep
isol
robust
expans
aapc
lap
repurif
obtain
highli
purifi
bona
fide
treg
ultim
clinic
investig
appli
techniqu
defin
treg
patient
immunolog
condit
gener
highli
purifi
treg
product
therapeut
use
highli
purifi
treg
product
ex
vivo
expans
would
reduc
potenti
advers
reaction
would
also
enhanc
efficaci
interpret
multicent
clinic
trial
treg
immunotherapi
variou
fluoresc
conjug
antibodi
human
lap
garp
biolegend
cell
surfac
stain
first
use
appropri
combin
mab
either
use
directli
flow
cytometr
analys
process
intracellular
stain
cytokin
helio
cell
fix
permeabil
fixationpermeabil
kit
ebiosci
stain
andor
antihelio
mab
biolegend
facscalibur
attun
flow
cytomet
use
data
acquisit
data
analyz
flowjo
softwar
treestar
antibiotin
magnet
microbead
miltenyi
biotec
cell
cultur
complet
media
consist
rpmi
supplement
heatinactiv
fetal
bovin
serum
fb
penicillin
uml
streptomycin
gibco
mem
nonessenti
amino
acid
sodium
pyruv
hyclon
peripher
blood
mononuclear
cell
pbmc
isol
adult
peripher
buffi
coat
gulf
coast
region
blood
center
ficol
gradient
centrifug
treg
purifi
pbmc
posit
select
use
directli
conjug
magnet
microbead
automac
program
beadpurifi
cell
stimul
artifici
apc
aapc
express
ratio
kindli
provid
dr
carl
h
june
dr
jame
l
riley
cell
load
mab
biolegend
cell
cultur
complet
media
supplement
uml
peprotech
presenc
nm
rapamycin
sigmaaldrich
cell
cultur
cultur
flask
thermofish
scientif
day
cell
transfer
cultur
flask
addit
fresh
complet
media
contain
uml
addit
rapamycin
ad
cultur
except
first
day
day
cell
transfer
cultur
flask
fresh
media
cultur
maintain
cell
concentr
split
everi
day
addit
fresh
media
day
cell
spun
given
fresh
media
restimul
addit
load
cell
aapc
stimul
cell
analyz
purifi
base
express
lap
lap
cell
isol
biotinyl
antihlap
mab
biolegend
follow
secondari
incub
antibiotin
magnet
microbead
miltenyi
biotec
use
lap
treg
purifi
expand
cell
posit
select
automac
program
lap
lap
popul
cultur
fresh
media
maintain
cell
concentr
split
everi
day
addit
fresh
media
day
popul
got
stimul
cell
ratio
cell
isol
pbmc
healthi
donor
buffi
coat
use
automac
relat
miltenyi
biotec
kit
fresh
cell
label
cfse
invitrogen
stimul
nonirradi
apc
load
alon
respond
suppressor
cell
lap
treg
lap
cell
cell
cultur
day
flatbottom
plate
corn
cfse
dilut
analyz
fac
analysi
intracellular
cytokin
product
cell
stimul
hour
ngml
pma
ionomycin
brefeldin
sigmaaldrich
afterward
cell
fix
permeabil
ebiosci
kit
stain
mab
biolegend
fac
analysi
nsg
mice
obtain
jackson
laboratori
maintain
specif
pathogen
free
condit
clamc
univers
texa
health
scienc
center
houston
protocol
mice
irradi
day
mice
inject
human
without
expand
lap
treg
nontreg
follow
inject
cell
anim
monitor
twice
week
weight
loss
sign
xgvhd
eg
hunch
back
ruffl
fur
reduc
mobil
mice
euthan
experienc
weight
loss
show
sign
compromis
health
consid
human
graftrel
diseas
expand
popul
human
cell
detect
simultan
blood
mice
evalu
human
cell
blood
flow
cytomet
weekli
day
euthan
document
cell
expans
anim
bled
red
blood
cell
lyse
ack
lyse
buffer
qualiti
biolog
inc
anim
protocol
approv
clamc
univers
texa
health
scienc
center
houston
determin
methyl
statu
gene
dna
purifi
frozen
aliquot
expand
lap
treg
nontreg
code
sampl
sent
epionti
berlin
germani
bisulfit
modif
quantif
tsdr
methyl
epigenet
human
qpcr
assay
cell
receptor
tcr
repertoir
analyz
use
flow
cytometri
iotest
beta
mark
tcr
repertoir
kit
beckman
coulter
consist
fluorochrom
conjug
monoclon
antibodi
identifi
tcr
subfamili
cover
normal
human
cell
repertoir
statist
analys
perform
use
graphpad
prism
graphpad
softwar
san
diego
ca
data
analyz
analysi
varianc
anova
student
test
group
result
express
mean
plu
minu
sem
state
otherwis
pair
student
test
use
comparison
group
valu
discriminatori
paramet
appropri
surviv
data
analyz
spss
softwar
version
spss
inc
chicago
il
usa
use
kaplanmei
method
compar
use
logrank
test
p
valu
less
consid
signific
previous
demonstr
feasibl
econom
use
initi
onestep
method
bead
purifi
expand
treg
bead
time
use
aapc
costeffect
larg
scale
product
requir
remov
process
figur
show
expans
reisol
protocol
instead
previous
isol
lap
treg
day
round
stimul
time
isol
lap
treg
round
stimul
day
choos
approach
reduc
amount
antilap
mab
sinc
cell
number
cultur
less
method
popul
contain
averag
cell
within
cell
rang
percentag
puriti
post
lap
purif
lap
typic
popul
still
treg
left
furthermor
lap
cell
mainli
garp
cell
figur
start
lap
treg
day
abl
achiev
billion
lap
treg
day
expans
figur
start
popul
day
contain
mainli
treg
remaind
b
nk
cell
figur
expans
contamin
nont
cell
disappear
day
furthermor
cell
popul
mainli
found
popul
repurif
figur
progress
reduct
puriti
popul
expans
averag
rang
start
point
mean
rang
day
rang
day
lap
repurif
mean
cell
maintain
higher
lap
treg
lower
popul
expans
figur
mean
percentag
cell
maintain
higher
lap
treg
lower
popul
expans
figur
e
order
investig
chang
tcr
repertoir
expans
next
examin
tcr
repertoir
usag
treg
day
day
expans
three
round
stimul
lap
purif
total
treg
tcr
usag
essenti
unchang
day
day
figur
b
figur
show
data
three
repres
donor
tcr
distribut
expans
effector
cell
secret
cytokin
exacerb
gvhd
cardin
featur
treg
anerg
state
lap
treg
nontreg
stimul
measur
level
cytokin
product
day
end
cultur
substanti
lower
percentag
produc
cell
cell
detect
lap
treg
compar
two
popul
figur
level
methyl
promot
region
upstream
term
tregspecif
demethyl
region
tsdr
provid
specif
differenti
activ
effector
cell
bona
fide
treg
sever
studi
demonstr
cell
fulli
methyl
site
itreg
intermedi
ttreg
fulli
demethyl
level
demethyl
tsdr
region
critic
establish
stabl
treg
lineag
correl
suppress
function
studi
demonstr
day
expans
purifi
lap
treg
highli
demethyl
averag
demethyl
tsdr
region
cell
mean
demethyl
figur
nontreg
highli
methyl
less
demethyl
even
popul
contain
close
helio
cell
figur
c
note
popul
still
contain
lap
cell
rang
repres
demethyl
tsdr
helio
signal
figur
previous
demonstr
lap
treg
isol
dynabead
stimul
expans
cultur
maintain
suppress
function
sinc
lap
treg
obtain
aapc
stimul
expans
cultur
import
confirm
suppress
function
evalu
capac
purifi
lap
treg
suppress
prolif
respons
cell
cfse
dilut
assay
expect
lap
treg
potent
suppressor
among
three
popul
figur
b
determin
whether
expand
lap
treg
effect
suppress
human
pbmcinduc
xenogen
gvhd
use
xenogen
model
gvhd
treg
cotransf
ratio
allogen
pbmc
nsg
recipi
compar
potenc
safeti
vitroexpand
lap
treg
lap
cell
figur
administ
alon
result
median
surviv
day
cotransf
lap
parent
lap
treg
increas
median
surviv
p
day
p
respect
lap
nontreg
show
similar
median
surviv
day
pbmc
group
surviv
lap
group
significantli
higher
lap
group
p
compar
group
lap
treg
increas
median
surviv
day
howev
statist
differ
found
sinc
parent
popul
less
contamin
nontreg
therefor
higher
level
treg
figur
averag
bodi
weight
initi
weight
mice
surviv
given
day
differ
group
shown
figur
adopt
transfer
treg
prevent
cure
multipl
autoimmun
diseas
gvhd
proven
highli
efficaci
anim
model
human
major
obstacl
overcom
achiev
consist
highli
purifi
treg
product
ex
vivo
expans
costeffect
manner
studi
use
lap
uniqu
cell
surfac
marker
distinguish
bona
fide
treg
activ
nontreg
show
feasibl
sort
expand
treg
nontreg
base
express
lap
obtain
postsort
puriti
greater
would
ideal
cellular
immunotherapi
furthermor
find
ex
vivo
expand
lap
treg
aapc
maintain
tcr
repertoir
divers
instead
clonal
expans
due
select
cell
death
similar
data
detect
expand
cord
blood
cb
treg
process
ex
vivo
expans
skew
cb
treg
tcr
repertoir
although
possibl
obtain
highli
purifi
popul
restimul
expand
cell
also
shown
effector
cell
transient
possess
featur
particularli
repeat
vitro
stimul
moreov
sever
studi
point
potenti
plastic
treg
caution
instabl
could
result
gener
pathogen
memori
cell
vivo
studi
quantit
assay
assess
anerg
state
treg
use
detect
cytokin
secret
minim
percentag
detect
purifi
lap
treg
compar
popul
method
offer
opportun
reduc
cytokin
secret
cell
cultur
compar
rapamycin
cultur
system
still
cell
secret
cell
fourth
restimul
studi
minim
percentag
lap
treg
cell
secret
lap
cell
mainli
garp
cell
immunosuppress
role
lap
might
garplap
complex
glycoprotein
repetit
predomin
garp
also
known
leucin
rich
repeat
contain
play
import
role
immunosuppress
function
treg
inhibit
effector
cell
activ
target
garp
sirna
monoclon
antibodi
specif
garp
inhibit
immunosuppress
activ
treg
vitro
vivo
howev
role
lapgarp
treg
remain
unclear
controversi
delet
garp
mous
treg
suffici
inhibit
growth
transplant
tumor
found
suppress
function
treg
affect
knockout
garp
treg
studi
need
reveal
mechan
respons
suppress
function
lap
treg
treg
repres
heterogen
popul
compris
commit
lineag
uncommit
subpopul
development
plastic
therefor
crucial
certifi
final
treg
product
consist
commit
treg
lineag
possess
stabl
phenotyp
highest
puriti
possibl
reliabl
method
quantif
demethyl
tsdr
correl
posit
treg
phenotyp
function
epigenet
marker
highli
specif
treg
discrimin
activ
convent
cell
compar
lap
treg
signific
level
tsdr
methyl
demonstr
lap
nontreg
even
day
expans
purifi
lap
treg
highli
demethyl
tsdr
region
lap
popul
contain
cell
yet
tsdr
demethyl
support
cell
bona
fide
treg
adopt
transfer
lap
treg
delay
develop
xenogen
gvhd
find
support
prior
observ
show
garp
treg
protect
xgvhd
dr
luca
group
found
administr
antibodi
block
garp
abrog
protect
treg
xgvhd
abl
demonstr
suppress
function
lap
treg
assay
limit
although
lap
treg
demonstr
suppress
function
delay
develop
xenogen
gvhd
unabl
detect
exist
peripher
blood
spleen
nsg
mice
day
post
adopt
transfer
similar
find
parmar
et
al
previous
shown
ex
vivoexpand
cord
blood
treg
nsg
xenogen
model
persist
beyond
day
one
possibl
explan
might
due
cytokin
depriv
particularli
enhanc
stabil
lap
treg
critic
develop
efficaci
cell
therapi
point
unclear
whether
lack
persist
intrins
human
treg
extrins
due
absenc
critic
growth
factor
compat
human
treg
nsg
mice
studi
need
answer
two
issu
absenc
repurif
process
final
expand
treg
product
would
highli
variabl
content
bona
fide
treg
contamin
expand
nontreg
figur
address
issu
protocol
implement
rapamycin
improv
percentag
treg
variabl
still
exist
consist
studi
expand
popul
maintain
tsdr
demethyl
figur
popul
possess
suffici
suppress
function
similar
repurifi
lap
treg
figur
c
unabl
demonstr
statist
differ
popul
lap
treg
due
high
variabl
treg
percentag
within
popul
therefor
would
prudent
manufactur
highli
purifi
treg
immunotherapi
similar
standard
requir
convent
drug
manufactur
regardless
variabl
bona
fide
treg
within
final
product
implement
lap
repurif
would
normal
produc
highli
purifi
homogen
treg
product
overal
studi
provid
greater
character
lap
treg
support
therapeut
applic
gvhd
autoimmun
condit
regardless
method
strategi
use
expand
treg
coexpans
cell
particularli
nontreg
almost
inevit
applic
lap
garp
repurif
highli
purifi
tsdr
demethyl
treg
popul
achiev
maintain
divers
function
next
step
demonstr
safeti
stabil
function
human
clinic
trial
